IRS1 and breast carcinoma: Phosphorylated IRS-1 Y612 protein was expressed in the majority of paraffin-embedded breast cancer clinical samples (range, 0 to 220; median, 61) as assessed by immunocytochemical analysis, with immunostaining localised predominantly at the plasma membrane, although some cytoplasmic staining was also observed (Figure 7a).